✦ LIBER ✦

Interleukin-2 and lymphokine activated killer cells

✍ Scribed by Hamblin, Terry J.

Book ID: 123446948
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 816 KB
Volume: 12
Category: Article
ISSN: 0955-3886
DOI: 10.1016/0955-3886(91)90007-P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion of recombinant inter

Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies

✍ Christiansen, Neal P. ;Kennedy, B. J. ;Ochoa, Augusto C. ;Skubitz, Keith M. ;Bac 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Severe intrahepatic cholestasis in patie

Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells

✍ Mitchel Hoffman; Abraham Mittelman; Brad Dworkin; William Rosenthal; Deborah Ben 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 1014 KB

Bone marrow granulomas in acute myeloid

Bone marrow granulomas in acute myeloid leukaemia following interleukin 2 and lymphokine-activated killer cells

✍ D.V. O'BRIEN; A.P. BOON; B.J. BOUGHTON 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

A regimen of surgical adjuvant immunothe

A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells

✍ Tokujiro Yano; Teruyoshi Ishida; Ichiro Yoshino; Mitsuhiro Murata; Kosei Yasumot 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 670 KB

Immunomodulatory effects of systemic low

Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans

✍ Timothy J. Eberlein; Mary L. Rodrick; Anthony F. Massaro; Sung-Eun Jung; John A. 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 799 KB

The requirements for successful immunoth

The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells

✍ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the